Edmunds David M, Gothard Lone, Khabra Komel, Kirby Anna, Madhale Poonam, McNair Helen, Roberts David, Tang K K, Symonds-Tayler Richard, Tahavori Fatemeh, Wells Kevin, Donovan Ellen
Department of Physics, The Royal Marsden NHS Foundation Trust, London, UK.
The Institute of Cancer Research, London, UK.
J Appl Clin Med Phys. 2018 May;19(3):71-78. doi: 10.1002/acm2.12286. Epub 2018 Mar 13.
Voluntary inspiration breath hold (VIBH) for left breast cancer patients has been shown to be a safe and effective method of reducing radiation dose to the heart. Currently, VIBH protocol compliance is monitored visually. In this work, we establish whether it is possible to gate the delivery of radiation from an Elekta linac using the Microsoft Kinect version 2 (Kinect v2) depth sensor to measure a patient breathing signal. This would allow contactless monitoring during VMAT treatment, as an alternative to equipment-assisted methods such as active breathing control (ABC). Breathing traces were acquired from six left breast radiotherapy patients during VIBH. We developed a gating interface to an Elekta linac, using the depth signal from a Kinect v2 to control radiation delivery to a programmable motion platform following patient breathing patterns. Radiation dose to a moving phantom with gating was verified using point dose measurements and a Delta4 verification phantom. 60 breathing traces were obtained with an acquisition success rate of 100%. Point dose measurements for gated deliveries to a moving phantom agreed to within 0.5% of ungated delivery to a static phantom using both a conventional and VMAT treatment plan. Dose measurements with the verification phantom showed that there was a median dose difference of better than 0.5% and a mean (3% 3 mm) gamma index of 92.6% for gated deliveries when using static phantom data as a reference. It is possible to use a Kinect v2 device to monitor voluntary breath hold protocol compliance in a cohort of left breast radiotherapy patients. Furthermore, it is possible to use the signal from a Kinect v2 to gate an Elekta linac to deliver radiation only during the peak inhale VIBH phase.
对于左乳癌患者,自主吸气屏气(VIBH)已被证明是一种降低心脏辐射剂量的安全有效方法。目前,VIBH方案的依从性通过视觉监测。在这项工作中,我们确定是否可以使用微软Kinect v2深度传感器来测量患者的呼吸信号,从而控制医科达直线加速器的辐射输送。这将允许在容积调强弧形治疗(VMAT)期间进行非接触式监测,作为主动呼吸控制(ABC)等设备辅助方法的替代方案。在VIBH期间,从6名左乳放疗患者身上采集了呼吸轨迹。我们开发了一个与医科达直线加速器的门控接口,利用Kinect v2的深度信号,根据患者的呼吸模式控制向可编程运动平台的辐射输送。通过点剂量测量和Delta4验证模体,验证了门控情况下移动模体的辐射剂量。获得了60条呼吸轨迹,采集成功率为100%。使用传统和VMAT治疗计划时,向移动模体进行门控照射的点剂量测量结果与向静态模体进行非门控照射的结果相差在0.5%以内。以静态模体数据为参考时,使用验证模体进行的剂量测量表明,门控照射的中位剂量差异优于0.5%,平均(3% 3毫米)伽马指数为92.6%。使用Kinect v2设备监测左乳放疗患者队列中的自主屏气方案依从性是可行的。此外,利用Kinect v2的信号来控制医科达直线加速器仅在吸气VIBH峰值阶段进行辐射输送也是可行的。